Abstract
Nausea and vomiting are common in advanced cancer and can have many causes. Successful treatment is possible in most patients when the clinician combines the history, symptoms, clinical examination and information about the patient's tumour, with existing knowledge about the mechanisms of nausea and vomiting. In this way antiemetics can be targeted at specific causes.
Get full access to this article
View all access options for this article.
References
1.
Dunlop GM
A study of the relative frequency and importance of gastrointestinal symptoms and weakness in patients with far-advanced cancer . Palliative Medicine
1989 ; 4 : 37 -43 .
2.
Allan SG
Emesis in the patient with advanced cancer . Palliative Medicine
1988 ; 2 : 89 -100 .
3.
Peroutka SJ
,
Snyder SH
Antiemetics: neurotransmitter receptor binding predicts therapeutic actions . Lancet
1982 ; i : 658 -59 .
4.
Hanks GW
Antiemetics for terminal cancer patients . Lancet
1982 ; i : 1410 .
5.
Regnard C.
,
Pashley S.
,
Westrope F.
Antiemetic/ diamorphine mixture compatibility in infusion pumps . Br J Pharm Pract
1986 ; 8 : 218 -20 .
6.
Allwood MC
The stability of diamorphine alone and in combination with antiemetics in plastic syringes . Palliative Medicine
1991 ; 5 : 330 -33 .
7.
Ashby MA
,
Game PA
,
Britten-Jones R.
et al. Percutaneous gastrostomy as a venting procedure . Palliative Medicine
1991 ; 5 : 147 -50 .
8.
Dundee JW
,
McMillan C.
Positive evidence for P6 acupuncture antiemesis . Postgrad Med J
1991 ; 67 : 417 -22 .
9.
Twycross RG
,
Lack SA
Control of Alimentary Symptoms in Far Advanced Cancer . Edinburgh : Churchill Livingstone , 1986 .